Betimol (timolol) NDC 82584-002

NDC codes

FDA NDC Directory

Product NDC (as listed)82584-002Labeler and product segments. Claims need a package NDC.

Product NDC at billing width82584-0002Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
82584-002-05	82584000205	1 BOTTLE, DROPPER in 1 CARTON (82584-002-05) / 5 mL in 1 BOTTLE, DROPPERMarketed from Nov 15, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Betimol
Generic name (nonproprietary): timolol
Active ingredients: Timolol — 5.12 mg/mL
Dosage form: Solution/ drops
Route: Ophthalmic
Labeler: Thea Pharma Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 020439
Marketing start: Nov 15, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 82584-002_3891d7f3-d858-9f71-e063-6394a90af95bSPL ID 3891d7f3-d858-9f71-e063-6394a90af95bSPL set ID 3ae775f4-340c-4bf4-aa49-8a31daba0f8bRxCUI 208560, 1992305, 2702393, 2702398UNII 817W3C6175UPC 0382584002053
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N482584000205 followed by a unit qualifier and the quantity

Package 82584-0002-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 27, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Betimol ® is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 020439

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 020439
Product	Strength	Form · route	Labeler	Product NDC
Betimoltimolol	Timolol 2.56 mg/mL	Solution/ dropsOphthalmic	Thea Pharma Inc.	82584-001